UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.554

Sortiert nach

Alzheimer's disease: clinical trials and drug development

Lancet neurology, 2010-07, Vol.9 (7), p.702-716

2010

Volltextzugriff (PDF)

The worldwide economic impact of dementia 2010

Alzheimer's & dementia, 2013-01, Vol.9 (1), p.1-11.e3

2013

Volltextzugriff (PDF)

The role of protein glycosylation in Alzheimer disease

The FEBS journal, 2014-01, Vol.281 (1), p.46-62

2014

Volltextzugriff (PDF)

The worldwide societal costs of dementia: Estimates for 2009

Alzheimer's & dementia, 2010-03, Vol.6 (2), p.98-103

2010

Volltextzugriff (PDF)

Small molecule therapeutics for tauopathy in Alzheimer’s disease: Walking on the path of most resistance

European journal of medicinal chemistry, 2021-01, Vol.209, p.112915-112915, Article 112915

2021

Volltextzugriff (PDF)

Defeating Alzheimer's disease and other dementias: a priority for European science and society

Lancet neurology, 2016-04, Vol.15 (5), p.455-532

2016

Volltextzugriff (PDF)

Prevalence of Chronic Diseases and Multimorbidity Among the Elderly Population in Sweden

American journal of public health (1971), 2008-07, Vol.98 (7), p.1198-1200

2008

Volltextzugriff (PDF)

Modulation of the endoplasmic reticulum–mitochondria interface in Alzheimer’s disease and related models

Proceedings of the National Academy of Sciences - PNAS, 2013-05, Vol.110 (19), p.7916-7921

2013

Volltextzugriff (PDF)

An active and socially integrated lifestyle in late life might protect against dementia

Lancet neurology, 2004-06, Vol.3 (6), p.343-353

2004

Volltextzugriff (PDF)

27-Hydroxycholesterol impairs neuronal glucose uptake through an IRAP/GLUT4 system dysregulation

The Journal of experimental medicine, 2017-03, Vol.214 (3), p.699-717

2017

Volltextzugriff (PDF)

The impact of the COVID-19 pandemic on neurosurgery in the elderly population in Sweden

BMC public health, 2024-03, Vol.24 (1), p.823-823, Article 823

2024

Volltextzugriff (PDF)

Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study

Lancet neurology, 2006-09, Vol.5 (9), p.735-741

2006

Volltextzugriff (PDF)

Patterns of Chronic Multimorbidity in the Elderly Population

Journal of the American Geriatrics Society (JAGS), 2009-02, Vol.57 (2), p.225-230

2009

Volltextzugriff (PDF)

Mild Cognitive Impairment in the General Population: Occurrence and Progression to Alzheimer Disease

The American journal of geriatric psychiatry, 2008-07, Vol.16 (7), p.603-611

2008

Volltextzugriff (PDF)

An App knock-in rat model for Alzheimer's disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments

Cell research, 2022-02, Vol.32 (2), p.157-175

2022

Volltextzugriff (PDF)

mTor mediates tau localization and secretion: Implication for Alzheimer's disease

Biochimica et biophysica acta, 2015-07, Vol.1853 (7), p.1646-1657

2015

Volltextzugriff (PDF)

Recent Advances in the Modeling of Alzheimer's Disease

Frontiers in neuroscience, 2022-03, Vol.16, p.807473

2022

Volltextzugriff (PDF)

SveDem, the Swedish Dementia Registry - a tool for improving the quality of diagnostics, treatment and care of dementia patients in clinical practice

PloS one, 2015-02, Vol.10 (2), p.e0116538-e0116538

2015

Volltextzugriff (PDF)

Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study

Lancet neurology, 2012-07, Vol.11 (7), p.597-604

2012

Volltextzugriff (PDF)

Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer’s disease

Acta neuropathologica, 2010-08, Vol.120 (2), p.185-193

2010

Volltextzugriff (PDF)

Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels

Alzheimer's research & therapy, 2017-08, Vol.9 (1), p.57-57, Article 57

2017

Volltextzugriff (PDF)

Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework

Neurobiology of aging, 2017-04, Vol.52, p.214-227

2017

Volltextzugriff (PDF)

amyloid β-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae

Proceedings of the National Academy of Sciences - PNAS, 2008-09, Vol.105 (35), p.13145-13150

2008

Volltextzugriff (PDF)

Toward a Predictive Model of Alzheimer’s Disease Progression Using Capillary Electrophoresis–Mass Spectrometry Metabolomics

Analytical chemistry (Washington), 2012-10, Vol.84 (20), p.8532-8540

2012

Volltextzugriff (PDF)

1 – 25 von 1.554

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.372)
Mit Volltextzugriff
(1.366)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Alzheimer's disease: clinical trials and drug development

The worldwide economic impact of dementia 2010

The role of protein glycosylation in Alzheimer disease

The worldwide societal costs of dementia: Estimates for 2009

Small molecule therapeutics for tauopathy in Alzheimer’s disease: Walking on the path of most resistance

Defeating Alzheimer's disease and other dementias: a priority for European science and society

Prevalence of Chronic Diseases and Multimorbidity Among the Elderly Population in Sweden

Modulation of the endoplasmic reticulum–mitochondria interface in Alzheimer’s disease and related models

An active and socially integrated lifestyle in late life might protect against dementia

Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial

27-Hydroxycholesterol impairs neuronal glucose uptake through an IRAP/GLUT4 system dysregulation

The impact of the COVID-19 pandemic on neurosurgery in the elderly population in Sweden

Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study

Patterns of Chronic Multimorbidity in the Elderly Population

Mild Cognitive Impairment in the General Population: Occurrence and Progression to Alzheimer Disease

An App knock-in rat model for Alzheimer's disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments

mTor mediates tau localization and secretion: Implication for Alzheimer's disease

Recent Advances in the Modeling of Alzheimer's Disease

SveDem, the Swedish Dementia Registry - a tool for improving the quality of diagnostics, treatment and care of dementia patients in clinical practice

Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study

Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer’s disease

Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels

Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework

amyloid β-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae

Toward a Predictive Model of Alzheimer’s Disease Progression Using Capillary Electrophoresis–Mass Spectrometry Metabolomics

Suchergebnisse filtern